CHESLEY TAFT & ASSOCIATES LLC/IL
Q1 2014 13F-HR Holdings
Net value change ($000)
-70,244
(-7.0%)
New positions
20
Sold out positions
39
Turnover %
11.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VZ | 6,100 | 260.9% |
| ENDOCYTE INC | 3,472 | 144.8% |
| PRGO | 3,430 | NEW |
| SALIX PHARMACEUTICAL | 3,360 | NEW |
| CVS | 3,201 | 65.3% |
| HSY | 2,694 | 185.4% |
| DKS | 2,471 | NEW |
| MA | 2,258 | 80.4% |
| WALGREEN CO | 1,826 | 13.9% |
| UNP | 1,824 | 11.6% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|